Genesis Biotechnology Group has completed the acquisition of PharmOptima, which will enable the former to provide its customers a single point-of-contact for the development and co-ordination of their unique pre-clinical drug development programme.

"Betta Pharmaceuticals has announced its intention to acquire 77.4% stake in AnewPharma."

The acquirer company is a US-based biotechnology firm, whereas the target company is a contract research organisation also based in the US.

Go deeper with GlobalData

Go deeper with GlobalData

The gold standard of business intelligence.

Find out more

Discover B2B Marketing That Performs

Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.

Find out more

Betta Pharmaceuticals has announced its intention to acquire 77.4% stake in AnewPharma.

Both companies involved in the transaction are pharmaceutical organisations based in China.

The purchase consideration for the acquisition is expected to be ¥371.6m ($54.08m).

GlobalData Strategic Intelligence

US Tariffs are shifting - will you react or anticipate?

Don’t let policy changes catch you off guard. Stay proactive with real-time data and expert analysis.

By GlobalData

Clinical Trials Arena Excellence Awards - Nominations Closed

Nominations are now closed for the Clinical Trials Arena Excellence Awards. A big thanks to all the organisations that entered – your response has been outstanding, showcasing exceptional innovation, leadership, and impact.

Excellence in Action
YPrime won the Innovation award for AI in Clinical Trials and the Environmental award for Sustainable Trials, thanks to its eCOA, IRT and eConsent platforms. Explore how purpose-built AI, paperless workflows and circular hardware practices are reshaping timelines, data quality and ESG performance in clinical research.

Discover the Impact